Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system
Open Access
- 7 April 2009
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 109 (3), 838-845
- https://doi.org/10.1111/j.1471-4159.2009.06010.x
Abstract
J. Neurochem. (2009) 109, 838–845. Abstract Enhanced delivery and expression of genes in specific neuronal systems is critical for the development of genetic models of neurodegenerative disease and potential gene therapy. Recent discovery of new recombinant adeno‐associated viral (rAAV) capsid serotypes has resulted in improved transduction efficiency, but expression levels, spread of transgene, and potential toxicity can differ depending on brain region and among species. We compared the transduction efficiency of titer‐matched rAAV 2/1, 2/5, and 2/8 to the commonly used rAAV2/2 in the rat nigrostriatal system via expression of the reporter transgene, enhanced green fluorescent protein. Newer rAAV serotypes 2/1, 2/5, and 2/8 demonstrated marked increase in transduction and spread of enhanced green fluorescent protein expression in dopaminergic nigrostriatal neurons and projections to the striatum and globus pallidus compared to rAAV2/2 at 2 weeks post‐injection. The number of nigral cells transduced was greatest for rAAV2/1, but for serotypes 2/5 and 2/8 was still two‐ to threefold higher than that for 2/2. Enhanced transduction did not cause an increase in glial cell response or toxicity. New rAAV serotypes thus promise improved gene delivery to nigrostriatal system with the potential for better models and therapeutics for Parkinson disease and other neurodegenerative disorders.Keywords
This publication has 34 references indexed in Scilit:
- Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitroVirology, 2008
- In vivo gene delivery for development of mammalian models for Parkinson's diseaseExperimental Neurology, 2007
- Dopaminergic neuron loss and up‐regulation of chaperone protein mRNA induced by targeted over‐expression of alpha‐synuclein in mouse substantia nigraJournal of Neurochemistry, 2006
- Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug DiscoveryNeuron, 2006
- Efficient Neuronal Gene Transfer with AAV8 Leads to Neurotoxic Levels of Tau or Green Fluorescent ProteinsMolecular Therapy, 2006
- Recombinant Adeno-Associated Viral Vectors in the Nervous SystemHuman Gene Therapy, 2005
- Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous SystemMolecular Therapy, 2004
- Transduction Profiles of Recombinant Adeno-Associated Virus Vectors Derived from Serotypes 2 and 5 in the Nigrostriatal System of RatsJournal of Virology, 2004
- Recombinant AAV-mediated gene delivery to the central nervous systemThe Journal of Gene Medicine, 2004
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991